Essentials for selecting antimicrobial therapy for intra-abdominal infections
about
Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceEfficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants.Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infectionsIntra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal TreatmentSpectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients.Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections.Intraabdominal infections in the intensive care unit.β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).Antimicrobial stewardship of β-lactams in intensive care units.Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.Basis for selecting optimum antibiotic regimens for secondary peritonitis.Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study.Acute and Chronic Infections of the Gastrointestinal Tract.Severe autogenously fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion. Response to intra peritoneal moxifloxacin combined with dexamethasone.Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
P2860
Q33640559-1E065C18-7212-4250-B432-6CA652EBF6BCQ34330502-17965E90-B08B-4F27-94D6-DCB523CDA278Q34785435-DB399E4D-E82D-4A51-979A-A4889005B4D5Q35536555-FA3C7E53-68E7-47B4-8AB4-4986B9DB058CQ36001726-70947C81-E4C9-481A-99A9-EF933AB26080Q36255276-7AE25964-01F9-4FCE-800E-0D35D7A002B3Q36736049-1C22997D-362E-4E79-88B9-68A83B3D090CQ38113473-5E17272D-68F1-44A5-9F0E-498B3E2C5664Q38130715-3D1CF5BF-B217-4F2A-9151-F6BB9EF37F3EQ38198157-E6E9B928-1A77-469F-A36E-CF8402DA4350Q38241417-50FCA312-A7F5-43A2-878B-50D48934BB47Q38325217-297619FB-94F8-49D8-AFDC-AC9AC654B439Q38633450-8C605B39-50B4-4131-905B-10730EEC0E44Q38650049-80FB9B39-54E6-4E6B-ABED-C8A029D64E51Q40690093-1D1F30BC-5B7F-477B-96B0-F7A4DBC1502BQ42001796-5445F284-8093-4E01-919E-6329519C0A02Q44778276-F61E424D-057E-4E6E-B31E-DC3A79ECD65FQ54290966-B4AC4F67-F9EE-4A1C-820F-10F6B28B804E
P2860
Essentials for selecting antimicrobial therapy for intra-abdominal infections
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@ast
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@en
type
label
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@ast
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@en
prefLabel
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@ast
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@en
P2093
P2860
P1433
P1476
Essentials for selecting antimicrobial therapy for intra-abdominal infections
@en
P2093
Dirk Vogelaers
Jan J De Waele
Stijn Blot
P2860
P304
P356
10.2165/11599800-000000000-00000
P577
2012-04-01T00:00:00Z
P5875
P6179
1014545176